FLGC - Flora Growth Corp.
8.95
-2.020 -22.570%
Share volume: 303,002
Last Updated: 01-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$10.97
-2.02
-0.18%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | 05-13-2025 | 08-01-2025 | 11-05-2025 | 02-27-2026 | |
| Assets | |||||||||
| Total Assets | 24.274 M | 30.083 M | 29.284 M | 26.227 M | 22.395 M | 22.667 M | 74.016 M | 130.235 M | |
| Current Assets | 21.767 M | 21.362 M | 21.288 M | 19.763 M | 13.217 M | 13.197 M | 18.090 M | 8.716 M | |
| Inventories | 9.246 M | 6.747 M | 7.857 M | 5.771 M | 4.792 M | 4.801 M | 2.483 M | 1.897 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.141 M | 98.000 K | 76.000 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 4.156 M | 6.127 M | 4.209 M | 6.017 M | 3.676 M | 1.471 M | 13.100 M | 5.596 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 786.000 K | 806.000 K | 518.000 K | 312.000 K | 354.000 K | 414.000 K | 151.000 K | 128.000 K | |
| Other Assets | 1.721 M | 7.915 M | 7.478 M | 6.152 M | 8.824 M | 9.056 M | 55.775 M | 121.391 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 24.274 M | 30.083 M | 29.284 M | 26.227 M | 22.395 M | 22.667 M | 74.016 M | 130.235 M | |
| Total liabilities | 21.136 M | 21.810 M | 24.097 M | 21.717 M | 17.637 M | 18.644 M | 9.096 M | 59.683 M | |
| Total current liabilities | 19.319 M | 18.384 M | 20.893 M | 18.832 M | 12.590 M | 13.808 M | 8.697 M | 8.628 M | |
| Accounts Payable | 5.005 M | 4.620 M | 6.654 M | 5.464 M | 3.867 M | 3.807 M | 2.961 M | 2.328 M | |
| Other liabilities | 1.817 M | 2.398 M | 2.233 M | 2.029 M | 2.125 M | 1.965 M | 307.000 K | 279.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 2.052 M | 1.995 M | 64.000 K | 50.767 M | |
| Other liabilities | 1.817 M | 2.398 M | 2.233 M | 2.029 M | 2.125 M | 1.965 M | 307.000 K | 279.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.138 M | 7.309 M | 4.250 M | 4.510 M | 4.758 M | 4.023 M | 64.920 M | 70.552 M | |
| Common stock | 148.871 M | 155.678 M | 156.075 M | 162.871 M | 163.852 M | 165.082 M | 232.609 M | 348.160 M | |
| Retained earnings | -145.620 M | -148.237 M | -152.010 M | -158.140 M | -158.898 M | -161.310 M | -167.885 M | -277.788 M |